Porphyria: awareness is the key to diagnosis!. Issue 3 (4th May 2022)

• Record Type: Journal Article
• Authors: Heymans, Benjamin; Meersseman, Wouter
• Is Part Of: Acta clinica belgica. Volume 77:Issue 3(2022)
• Page Start: 703
• Page End: 709
• Publication Date: 2022-05-04
• Subjects: Porphyria -- photodermatoses -- seizure -- therapy -- metabolic disease; Clinical medicine -- Periodicals; Diagnosis, Laboratory -- Periodicals; 616.005
• DOI: 10.1080/17843286.2021.1918876
• Languages: English
• ISSNs: 1784-3286

Abstract

ABSTRACT: Porphyrias are disorders of the haem biosynthesis which are encountered infrequently and which often present themselves atypically as a combination of gastrointestinal, neurologic and/or dermatologic symptoms. Although they are primarily caused by enzyme defects, inheritance patterns are mostly not evident. Considering all of these characteristics, it is not surprising that there is a long delay between the onset of symptoms and the diagnosis of the disease, with as possible consequences impaired quality of life, irreversible neurologic damage and even death. This review aims to increase the clinical suspicion of the three most common porphyrias in adults: acute intermittent porphyria (AIP), porphyria cutanea tarda (PCT) and protoporphyria. Their relevant pathophysiology, clinical manifestations, diagnosis and treatment are discussed aiming at increasing the awareness of these diseases among physicians.